Avid Bioservices (CDMO) Tops Q4 EPS by 12c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. LEVI
2. STZ
3. APLD
4. CRGY
5. PEP
6. DVN
7. ANGO
8. RMR
9. LULU
10. SPCX

Go back to Avid Bioservices (CDMO) Tops Q4 EPS by 12c

Avid Bioservices Reports Financial Results for Quarter and Fiscal Year Ended April 30, 2018 and Recent Developments

July 16, 2018 4:05 PM EDT

-- Company Records Fiscal Year 2018 Revenue of $53.6 Million --

-- Committed Backlog Increases to $57.8 Million (ASC 605) --

-- Customer Base Expanded and Diversified --

-- Key Appointments Strengthen CDMO Leadership Team --

TUSTIN, Calif., July 16, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO) (NASDAQ: CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical... More